메뉴 건너뛰기




Volumn 9, Issue , 2010, Pages

Effect of candesartan monotherapy on lipid metabolism in patients with hypertension: A retrospective longitudinal survey using data from electronic medical records

Author keywords

[No Author keywords available]

Indexed keywords

CANDESARTAN HEXETIL; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; CANDESARTAN; LIPID; TETRAZOLE DERIVATIVE;

EID: 77955549185     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-9-38     Document Type: Article
Times cited : (23)

References (27)
  • 1
    • 8544251308 scopus 로고    scopus 로고
    • Telmisartan - killing two birds with one stone
    • 10.1517/14656566.5.11.2397, 15500387
    • Doggrell SA. Telmisartan - killing two birds with one stone. Expert Opin Pharmacother 2004, 5:2397-2400. 10.1517/14656566.5.11.2397, 15500387.
    • (2004) Expert Opin Pharmacother , vol.5 , pp. 2397-2400
    • Doggrell, S.A.1
  • 2
    • 36649033813 scopus 로고    scopus 로고
    • Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records
    • 10.1186/1475-2840-6-26, 2098751, 17903269
    • Kitamura N, Takahashi Y, Yamadate S, Asai S. Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records. Cardiovasc Diabetol 2007, 6:26. 10.1186/1475-2840-6-26, 2098751, 17903269.
    • (2007) Cardiovasc Diabetol , vol.6 , pp. 26
    • Kitamura, N.1    Takahashi, Y.2    Yamadate, S.3    Asai, S.4
  • 3
    • 0037534905 scopus 로고    scopus 로고
    • The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial
    • 10.1097/00004872-200305000-00011, 12714861, SCOPE Study Group
    • Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A, . SCOPE Study Group The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 2003, 21:875-886. 10.1097/00004872-200305000-00011, 12714861, SCOPE Study Group.
    • (2003) J Hypertens , vol.21 , pp. 875-886
    • Lithell, H.1    Hansson, L.2    Skoog, I.3    Elmfeldt, D.4    Hofman, A.5    Olofsson, B.6    Trenkwalder, P.7    Zanchetti, A.8
  • 4
    • 0038261970 scopus 로고    scopus 로고
    • The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors
    • 10.1161/01.STR.0000075777.18006.89, 12817109, Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group
    • Schrader J, Lüders S, Kulschewski A, Berger J, Zidek W, Treib J, Einhäupl K, Diener HC, Dominiak P, . Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 2003, 34:1699-1703. 10.1161/01.STR.0000075777.18006.89, 12817109, Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group.
    • (2003) Stroke , vol.34 , pp. 1699-1703
    • Schrader, J.1    Lüders, S.2    Kulschewski, A.3    Berger, J.4    Zidek, W.5    Treib, J.6    Einhäupl, K.7    Diener, H.C.8    Dominiak, P.9
  • 5
    • 0042410539 scopus 로고    scopus 로고
    • Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme
    • 10.1016/S0140-6736(03)14282-1, 13678868, CHARM Investigators and Committees
    • Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Yusuf S, Pocock S, . CHARM Investigators and Committees Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003, 362:759-766. 10.1016/S0140-6736(03)14282-1, 13678868, CHARM Investigators and Committees.
    • (2003) Lancet , vol.362 , pp. 759-766
    • Pfeffer, M.A.1    Swedberg, K.2    Granger, C.B.3    Held, P.4    McMurray, J.J.5    Michelson, E.L.6    Olofsson, B.7    Ostergren, J.8    Yusuf, S.9    Pocock, S.10
  • 6
    • 33751068479 scopus 로고    scopus 로고
    • Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma
    • 10.1016/j.ejphar.2006.08.062, 1764497, 17064684
    • Zorad S, Dou JT, Benicky J, Hutanu D, Tybitanclova K, Zhou J, Saavedra JM. Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma. Eur J Pharmacol 2006, 552:112-122. 10.1016/j.ejphar.2006.08.062, 1764497, 17064684.
    • (2006) Eur J Pharmacol , vol.552 , pp. 112-122
    • Zorad, S.1    Dou, J.T.2    Benicky, J.3    Hutanu, D.4    Tybitanclova, K.5    Zhou, J.6    Saavedra, J.M.7
  • 8
    • 0036138569 scopus 로고    scopus 로고
    • Report of the Committee on the classification and diagnostic criteria of diabetes mellitus
    • 10.1016/S0168-8227(01)00365-5, 11755481, Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus
    • Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, Shima K, Nonaka K, Kadowaki T, . Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract 2002, 55:65-85. 10.1016/S0168-8227(01)00365-5, 11755481, Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus.
    • (2002) Diabetes Res Clin Pract , vol.55 , pp. 65-85
    • Kuzuya, T.1    Nakagawa, S.2    Satoh, J.3    Kanazawa, Y.4    Iwamoto, Y.5    Kobayashi, M.6    Nanjo, K.7    Sasaki, A.8    Seino, Y.9    Ito, C.10    Shima, K.11    Nonaka, K.12    Kadowaki, T.13
  • 9
    • 70350776529 scopus 로고    scopus 로고
    • Good research practices for comparative effectiveness research: analytic method to improve casual inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR good research practices for retrospective database analysis task force report-part III
    • 10.1111/j.1524-4733.2009.00602.x, 19793071
    • Johnson ML, Crown W, Martin BC, Dormuth CR, Siebert U. Good research practices for comparative effectiveness research: analytic method to improve casual inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR good research practices for retrospective database analysis task force report-part III. Value Health 2009, 12:1062-1073. 10.1111/j.1524-4733.2009.00602.x, 19793071.
    • (2009) Value Health , vol.12 , pp. 1062-1073
    • Johnson, M.L.1    Crown, W.2    Martin, B.C.3    Dormuth, C.R.4    Siebert, U.5
  • 10
    • 77951622706 scopus 로고
    • The central role of the propensity score in observational studies for causal effects
    • Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983, 70:41-55.
    • (1983) Biometrika , vol.70 , pp. 41-55
    • Rosenbaum, P.R.1    Rubin, D.B.2
  • 13
    • 0037076037 scopus 로고    scopus 로고
    • Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors
    • 10.1056/NEJMsa003087, 11893794
    • Schneeweiss S, Walker AM, Glynn RJ, Maclure M, Dormuth C, Soumerai SB. Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors. N Engl J Med 2002, 346:822-9. 10.1056/NEJMsa003087, 11893794.
    • (2002) N Engl J Med , vol.346 , pp. 822-829
    • Schneeweiss, S.1    Walker, A.M.2    Glynn, R.J.3    Maclure, M.4    Dormuth, C.5    Soumerai, S.B.6
  • 14
    • 0000724291 scopus 로고    scopus 로고
    • The role of the propensity score in estimating dose-response functions
    • Imbens GW. The role of the propensity score in estimating dose-response functions. Biometrika 2000, 87:706-710.
    • (2000) Biometrika , vol.87 , pp. 706-710
    • Imbens, G.W.1
  • 16
    • 77149163479 scopus 로고    scopus 로고
    • Evaluation health management programmes over time: application of propensity score-based weighting to longitudinal data
    • 10.1111/j.1365-2753.2009.01361.x, 20367830
    • Linden A, Adams JL. Evaluation health management programmes over time: application of propensity score-based weighting to longitudinal data. J Eval Clin Pract 2010, 16:180-185. 10.1111/j.1365-2753.2009.01361.x, 20367830.
    • (2010) J Eval Clin Pract , vol.16 , pp. 180-185
    • Linden, A.1    Adams, J.L.2
  • 17
    • 84870213416 scopus 로고    scopus 로고
    • Using propensity score to adjust for treatment selection bias
    • Leslie S, Thiebaud P. Using propensity score to adjust for treatment selection bias. SAS Global forum 2007 paper 184-2007 , http://www2.sas.com/proceedings/forum2007/184-2007.pdf
    • SAS Global forum 2007 paper 184-2007
    • Leslie, S.1    Thiebaud, P.2
  • 18
    • 3543135271 scopus 로고    scopus 로고
    • Tutorial on Biostatistics: Propensity Score Methods for Bias Reduction in the comparison of a treatment to a non-randomized control group
    • 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B, 9802183
    • D'Agostino R. Tutorial on Biostatistics: Propensity Score Methods for Bias Reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998, 17:2265-2281. 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B, 9802183.
    • (1998) Stat Med , vol.17 , pp. 2265-2281
    • D'Agostino, R.1
  • 19
    • 65349169001 scopus 로고    scopus 로고
    • Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment--a review
    • 10.1186/1475-2840-8-18, 2669450, 19327149
    • Bramlage P, Hasford J. Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment--a review. Cardiovasc Diabetol 2009, 8:18. 10.1186/1475-2840-8-18, 2669450, 19327149.
    • (2009) Cardiovasc Diabetol , vol.8 , pp. 18
    • Bramlage, P.1    Hasford, J.2
  • 20
    • 0038818552 scopus 로고    scopus 로고
    • Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension
    • 10.1161/01.HYP.0000078490.59735.6E, 12796280
    • Furuhashi M, Ura N, Higashiura K, Murakami H, Tanaka M, Moniwa N, Yoshida D, Shimamoto K. Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 2003, 42:76-81. 10.1161/01.HYP.0000078490.59735.6E, 12796280.
    • (2003) Hypertension , vol.42 , pp. 76-81
    • Furuhashi, M.1    Ura, N.2    Higashiura, K.3    Murakami, H.4    Tanaka, M.5    Moniwa, N.6    Yoshida, D.7    Shimamoto, K.8
  • 21
    • 77949484603 scopus 로고    scopus 로고
    • Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs
    • 10.1016/j.ijcard.2008.11.017, 2862263, 19059660
    • Koh KK, Quon MJ, Han SH, Lee Y, Kim SJ, Koh Y, Shin EK. Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs. Int J Cardiol 2010, 140:73-81. 10.1016/j.ijcard.2008.11.017, 2862263, 19059660.
    • (2010) Int J Cardiol , vol.140 , pp. 73-81
    • Koh, K.K.1    Quon, M.J.2    Han, S.H.3    Lee, Y.4    Kim, S.J.5    Koh, Y.6    Shin, E.K.7
  • 22
    • 0031710154 scopus 로고    scopus 로고
    • Antihypertensive treatment with candesartan cilexetil does not affect glucose homeostasis or serum lipid profile in patients with mild hypertension and type II diabetes
    • 10.1080/080370598437385, 9758087
    • Trenkwalder P, Dahl K, Lehtovirta M, Mulder H. Antihypertensive treatment with candesartan cilexetil does not affect glucose homeostasis or serum lipid profile in patients with mild hypertension and type II diabetes. Blood Press 1998, 7:170-175. 10.1080/080370598437385, 9758087.
    • (1998) Blood Press , vol.7 , pp. 170-175
    • Trenkwalder, P.1    Dahl, K.2    Lehtovirta, M.3    Mulder, H.4
  • 23
    • 0042703282 scopus 로고    scopus 로고
    • A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus
    • Derosa G, Cicero AF, Ciccarelli L, Fogari R. A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus. Clin Ther 2003, 25:1006-1021.
    • (2003) Clin Ther , vol.25 , pp. 1006-1021
    • Derosa, G.1    Cicero, A.F.2    Ciccarelli, L.3    Fogari, R.4
  • 24
    • 0037126526 scopus 로고    scopus 로고
    • Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report
    • National Cholesterol Education Program (NCEP) Expert Panel on Detection and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
    • National Cholesterol Education Program (NCEP) Expert Panel on Detection and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421. National Cholesterol Education Program (NCEP) Expert Panel on Detection and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
    • (2002) Circulation , vol.106 , pp. 3143-3421
  • 26
    • 77957126077 scopus 로고
    • Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
    • 10.1001/jama.273.3.199, 7807658, The writing group for PEPI trial
    • The writing group for PEPI trial Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995, 273:199-208. 10.1001/jama.273.3.199, 7807658, The writing group for PEPI trial.
    • (1995) JAMA , vol.273 , pp. 199-208
  • 27
    • 0002120165 scopus 로고    scopus 로고
    • Panel 3: methodological issues in conducting pharmacoeconomic evaluations--retrospective and claims database studies
    • 10.1046/j.1524-4733.1999.02204.x, 16674338
    • Arnold RG, Kotsanos JG. Panel 3: methodological issues in conducting pharmacoeconomic evaluations--retrospective and claims database studies. Value Health 1999, 2:82-87. 10.1046/j.1524-4733.1999.02204.x, 16674338.
    • (1999) Value Health , vol.2 , pp. 82-87
    • Arnold, R.G.1    Kotsanos, J.G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.